نتائج البحث - "Glucagon-Like Peptide-1 Receptor"

المصدر: Dagenais, G R, Rydén, L, Leiter, L A, Lakshmanan, M, Dyal, L, Probstfield, J L, Atisso, C M, Shaw, J E, Conget, I, Cushman, W C, Lopez-Jaramillo, P, Lanas, F, Munoz, E G C, Pirags, V, Pogosova, N, Basile, J, Sheu, W H H, Temelkova-Kurktschiev, T, Raubenheimer, P J, Keltai, M, Hall, S, Pais, P, Colhoun, H M, Riddle, M C & Gerstein, H C 2020, ' Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail : a post hoc analysis ', Cardiovascular diabetology, vol. 19, no. 1, pp. 199 . https://doi.org/10.1186/s12933-020-01179-1Test
Cardiovascular Diabetology

مصطلحات موضوعية: Male, medicine.medical_specialty, Time Factors, Recombinant Fusion Proteins, Endocrinology, Diabetes and Metabolism, Glucagon-Like Peptides, Type 2 diabetes, Placebo, Incretins, Risk Assessment, Glucagon-Like Peptide-1 Receptor, law.invention, Double-Blind Method, Randomized controlled trial, law, Internal medicine, medicine, Humans, Hypoglycemic Agents, Uncategorized, Original Investigation, Aged, Unstable angina, business.industry, Incidence (epidemiology), Hazard ratio, Middle Aged, Cardiovascular disease, medicine.disease, Glucagon like peptide-1 receptor agonists, Immunoglobulin Fc Fragments, Treatment Outcome, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Heart Disease Risk Factors, Female, Dulaglutide, Cardiology and Cardiovascular Medicine, business, Mace, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e03a38716bcec2e154f3ddff98a2ece2Test
https://doi.org/10.1186/s12933-020-01179-1Test

8

From glucose lowering agents to disease/diabetes modifying drugs: a 'SIMPLE' approach for the treatment of type 2 diabetes

المؤلفون: Antonio Ceriello, Meir Schechter, Lawrence A. Leiter, Ralph A. DeFronzo, Itamar Raz, Stefano Del Prato, Ofri Mosenzon

المصدر: Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-13 (2021)

مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, Glycated Hemoglobin A, Combination therapy, Endocrinology, Diabetes and Metabolism, Clinical Decision-Making, Population, Review, Glycemic Control, Type 2 diabetes, Disease, Hypoglycemia, Clinical approach, Lower risk, Incretins, Glucagon-Like Peptide-1 Receptor, Decision Support Techniques, Terminology as Topic, Internal medicine, Diabetes mellitus, Diabetes Mellitus, medicine, Diseases of the circulatory (Cardiovascular) system, Humans, Hypoglycemic Agents, Intensive care medicine, education, Sodium-Glucose Transporter 2 Inhibitors, Glycated Hemoglobin, education.field_of_study, Primary Health Care, business.industry, Patient Selection, medicine.disease, Type 2 Diabetes, Metformin, Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, Diabetes/Disease Modifying Drugs (DMDs), Biomarkers, Cardiology and Cardiovascular Medicine, business, Type 2, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d79c8e92b0cc27fb1720ba9195c4d12Test
https://doi.org/10.1186/s12933-021-01281-yTest

9

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

المؤلفون: Jan Škrha, Ilze Konrāde, Guntram Schernthaner, Fahim Ebrahimi, Alexander Ametov, Peter Fasching, Naim Shehadeh, Nebojsa Lalic, Péter Kempler, Žydrūnė Visockienė, Anna V. Bazarova, Emil Martinka, Andrej Janež, Tsvetalina Tankova, Cristian Serafinceanu, Dario Rahelić, Boris Mankovsky

المصدر: Cardiovascular diabetology [electronic resource], BioMed Central, 2020, vol. 19, iss. 1, art. no. 185, p. 1-17
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-17 (2020)
Cardiovascular Diabetology

مصطلحات موضوعية: Blood Glucose, lcsh:Diseases of the circulatory (Cardiovascular) system, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Clinical Decision-Making, Glycemic Control, Type 2 diabetes, Disease, Global Health, Incretins, Risk Assessment, Glucose lowering drugs, Glucagon-Like Peptide-1 Receptor, cardiorenal protection, clinical inertia, glucose lowering drugs, type 2 diabetes, Risk Factors, Internal medicine, Diabetes mellitus, medicine, Humans, Practice Patterns, Physicians', Medical prescription, Sodium-Glucose Transporter 2 Inhibitors, Angiology, Glucose lowering, Evidence-Based Medicine, High risk patients, business.industry, Cardiorenal protection, Protective Factors, medicine.disease, Clinical inertia, Treatment Outcome, Diabetes Mellitus, Type 2, Cardiovascular Diseases, lcsh:RC666-701, Heart failure, Practice Guidelines as Topic, Commentary, Kidney Diseases, Cardiology and Cardiovascular Medicine, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0730bfeff4fb75c30f0f6ccc4b51c36Test
https://doi.org/10.1186/s12933-020-01154-wTest

10

Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice

المؤلفون: Angelo Avogaro, Giovanni Sparacino, Gian Paolo Fadini, Enrico Longato, Lara Tramontan, Barbara Di Camillo

المصدر: Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-12 (2020)

مصطلحات موضوعية: Male, lcsh:Diseases of the circulatory (Cardiovascular) system, Time Factors, Databases, Factual, Epidemiology, Endocrinology, Diabetes and Metabolism, Type 2 diabetes, Drug therapy, Observational, Registry, outcome, Aged, Cardiovascular Diseases, Cause of Death, Diabetes Mellitus, Type 2, Dipeptidyl-Peptidase IV Inhibitors, Female, Glucagon-Like Peptide-1 Receptor, Humans, Incretins, Italy, Middle Aged, Patient Admission, Protective Factors, Retrospective Studies, Risk Assessment, Risk Factors, Treatment Outcome, Myocardial infarction, Stroke, Original Investigation, education.field_of_study, outcome, Cardiology and Cardiovascular Medicine, Type 2, Registry, medicine.medical_specialty, Population, Lower risk, Databases, Internal medicine, Diabetes mellitus, Diabetes Mellitus, medicine, education, Factual, business.industry, medicine.disease, lcsh:RC666-701, Heart failure, Propensity score matching, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a0a088072bbb75af305927c5a8217b6Test
https://doi.org/10.1186/s12933-020-01049-wTest

تنقيح النتائج